drugdeliverybusiness12h
Fractyl Health announces layoffs as it pivots to gene therapy
Fractyl Health (Nasdaq:GUTS) is cutting nearly a fifth of its workforce as it streamlines resources and shifts focus toward ...
drugdeliverybusiness15h
Modular Medical takes step forward in CE mark process for insulin pump tech
Modular Medical develops patented insulin delivery technologies, aiming to improve access to glycemic control. Its founder, ...
drugdeliverybusiness1d
Beta Bionics goes public with upsized $234.6M IPO
Beta Bionics announced today that it went public after pricing a significantly upsized initial public offering (IPO).
drugdeliverybusiness11d
Dexcom CEO says 2025 is ‘shaping up to be a good year’ with Stelo launch, GenAI integration
Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...
drugdeliverybusiness12d
Abbott Diabetes spurs growth with 22.7% uptick in CGM revenue, expects more insulin pump connectivity
Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.
drugdeliverybusiness2d
Trinity Biotech expects to submit ‘disruptive’ next-gen CGM to FDA in 2026
(Nasdaq:TRIB) announced new pre-pivotal clinical data supporting its next-generation continuous glucose monitor (CGM) system.
drugdeliverybusiness4d
Beta Bionics to raise $114.4M in IPO
Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO).
drugdeliverybusiness18d
Medtronic says it has next-gen insulin pumps on the way, more to come from diabetes business
The MiniMed 780G with the Simplera Sync CGM and accompanying devices. [Image courtesy of Medtronic] The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline ...